Correction to “Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases”

In the original version of this article, the authors Francisco Javier Chichón and Noelia Zamarreño were incorrectly not included in the authorship. This Correction contains the corrected Authorship, Author Information (affiliations), Author Contributions, Acknowledgments, and Supporting Information. The changes do not alter the major conclusions of this work.

Supporting Information Available

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.2c18984.

• Biophysical screening of the nanodiasome formulations composed of niosomes with nanodiamonds as helper component, physicochemical characterization of nanodiasomes at different ND/DOTMA mass ratios (including Figure S1 showing the data), transfection efficiency of nanodiasomes at different ND/DOTMA mass ratios, Figure S2 showing normalized percentages of EGFP positive live cells and cell viability, and description of the videos (PDF)

Author Contributions

^△ N.A.Q. and I.G. contributed equally. J.L.P., G.P.: Conceived the project. N.A.Q, I.G., A.J.P., C.S.S., G.M.N., M.S.R., T.B.L.M., N.Z.: Performed the experiments. N.A.Q., I.G., I.V.B., F.J.C.: Analyzed the results. N.A.Q., I.G.: Wrote the paper. N.A.Q., I.G, A.J.P., I.V.B., C.S.S, G.M.N., F.J.C.: Visualization. All authors: Reviewed-edited. J.L.P., G.P., E.F.: Supervision and project administration. J.L.P.: Funding acquisition. All authors have given approval to the final version of the manuscript.